单中心开放与闭合单元激光切割镍钛合金支架治疗慢性髂股静脉流出道梗阻的性能
单中心回顾性队列研究纳入2014至2019年接受专用镍钛静脉支架治疗的207例患者(开放单元100例,闭合单元107例),比较开放与闭合单元支架治疗单侧慢性髂静脉梗阻的结局。12个月原发通畅率开放单元63% vs 闭合单元65%,累积通畅率开放单元93% vs 闭合单元90%,两组相似。闭合单元支架跨腹股沟韧带者需多次再干预的风险高于开放单元支架者(OR 2.84,95%CI 1.16-6.9),但与原发通畅丧失显著相关的唯一因素是流入道血管病变(HR 3.39,95%CI 1.73-6.62,P<.001)。
要点
- 开放与闭合单元专用镍钛静脉支架12个月通畅率和症状改善相似。
- 闭合单元支架跨腹股沟韧带者一年内需多次再干预风险高于开放单元支架者(OR 2.84,95%CI 1.16-6.9)。
- 流入道血管病变是与原发通畅丧失显著相关的唯一因素(HR 3.39,95%CI 1.73-6.62,P<.001)。
核心结论
- 开放与闭合单元专用镍钛静脉支架在一年时的通畅率和症状改善方面表现相似。
- 流入道血管病变是与支架通畅丧失相关的最重要因素,与支架设计无关。
研究设计与样本
- 单中心回顾性队列研究,纳入2014至2019年接受专用镍钛静脉支架治疗的所有患者,共207例(开放单元100例,闭合单元107例)。
- 检查术后第一年的支架通畅性和再干预详情(包括溶栓、静脉成形术、加固、延长、动静脉瘘形成)。
- 亚组分析描述开放与闭合单元支架止于腹股沟韧带以上及需延伸至股总静脉的患者结局。
- 采用Cox回归分析识别与原发通畅丧失相关的因素。
主要发现
- 两组年龄(开放单元42岁,闭合单元44岁)、性别(开放与闭合单元均67%女性)、血栓后病变存在(开放单元71%,闭合单元73%)、跨腹股沟韧带支架(开放单元58%,闭合单元56%)及流入道病变存在(开放单元49%,闭合单元47%)无显著差异。
- 12个月原发通畅率开放单元63% vs 闭合单元65%,累积通畅率开放单元93% vs 闭合单元90%,两组相似。
- 闭合单元支架跨腹股沟韧带者一年内需多次再干预的风险高于开放单元支架者(OR 2.84,95%CI 1.16-6.9)。
- 与原发通畅丧失显著相关的唯一因素是流入道血管病变(HR 3.39,95%CI 1.73-6.62,P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A number of dedicated self expanding nitinol stents have been developed for use in the venous system, with both open cell (OC) and closed cell (CC) designs available. Data comparing these different designs are lacking. The objective of this study was to evaluate outcomes in patients treated with open and closed cells for unilateral chronic iliac vein obstruction. METHODS: A single centre retrospective cohort study was conducted, including all patients treated with a dedicated nitinol venous stent between 2014 and 2019. Stent patency and details of re-interventions (including lysis, venoplasty, reinforcement, extension, arteriovenous fistula formation) were examined in the first post-operative year. Subgroup analysis described outcomes for patients treated with OC and CC stents ending above the inguinal ligament and those who required extension into the common femoral vein. Cox regression analysis was used to identify factors associated with loss of primary patency. RESULTS: A total of 207 patients were included (OC 100 patients, CC 107 patients). There was no significant difference between the groups for age (OC 42 years, CC 44 years); gender (OC and CC 67% female); presence of post-thrombotic lesions (OC 71%, CC 73%); stenting across the inguinal ligament (OC 58%, CC 56%), or presence of inflow disease (OC 49%, CC 47%). Primary and cumulative patency at 12 months were similar between groups (primary: OC 63%, CC 65%; cumulative: OC 93%, CC 90%). Patients with a CC stent across the inguinal ligament had a greater risk of needing multiple re-interventions at one year compared with those with an OC stent (odds ratio 2.84, 95% confidence interval [CI] 1.16 - 6.9) but overall, the only factor significantly associated with loss of primary patency was inflow vessel disease (hazard ratio 3.39, 95% CI 1.73 - 6.62, p < .001). CONCLUSION: OC and CC dedicated nitinol venous stents were observed to perform similarly in terms of patency and symptom improvement at one year. Disease of the inflow vessels was the most important factor associated with a loss of stent patency irrespective of stent design.
引用
- Morris RI, Jackson N, Khan T, et al. Performance of Open and Closed Cell Laser Cut Nitinol Stents for the Treatment of Chronic Iliofemoral Venous Outflow Obstruction in Patients Treated at a Single Centre. Eur J Vasc Endovasc Surg. 2022. PMID: 35027274. doi:10.1016/j.ejvs.2021.10.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。